Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 572-578

  Marchesi, Marta ^a   Booth, Erin A ^b   Rossoni, Giuseppe ^a   García, Ricardo A ^c   Hill, Knut R ^c   Sirtori, Cesare R ^a   Bisgaier, Charles L ^b,c   Lucchesi, Benedict R ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Esperion Therapeutics Inc   (United States)

Author keywords

Antioxidant; Apolipoprotein A I; Apolipoprotein A IMilano; High density lipoproteins; Ischemia reperfusion injury

Indexed keywords

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; ANTIOXIDANT; APOLIPOPROTEIN A1; BUFFER; CREATINE KINASE; ETC 216; HIGH DENSITY LIPOPROTEIN; LIPID; LIPID HYDROPEROXIDE; LIPOPROTEIN; 1-PALMITOYL-2-OLEOYLPHOSPHATIDYLCHOLINE; APOLIPOPROTEIN A I MILANO; APOLIPOPROTEIN A-I MILANO; PHOSPHATIDYLCHOLINE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY RECANALIZATION; CORONARY REPERFUSION; ELECTRON MICROSCOPY; EX VIVO STUDY; HEART; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MUSCLE; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LIPID OXIDATION; MALE; MITOCHONDRION; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; SARCOMERE; ANIMAL; DISEASE MODEL; DRUG EFFECT; HEART VENTRICLE FUNCTION; LIPID PEROXIDATION; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEIN A-I; DISEASE MODELS, ANIMAL; LIPID PEROXIDATION; LIPOPROTEINS, HDL; MALE; MICROSCOPY, ELECTRON; MYOCARDIAL REPERFUSION INJURY; PHOSPHATIDYLCHOLINES; RABBITS; RECOMBINANT PROTEINS; VENTRICULAR DYSFUNCTION;

EID: 40949107218     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.08.028     Document Type: Article

References (27)

1. Franceschini G. Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease. Am J Cardiol 88 (2001) 9N-13N
2. Calabresi L., Rossoni G., and Franceschini G. Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injury. Pharmacol Ther 111 (2006) 836-854
3. Mackness M.I., Durrington P.N., and Mackness B. How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 11 (2000) 383-388
4. Calabresi L., Gomaraschi M., and Franceschini G. Endothelial protection by high-density lipoproteins: from bench to bedside. Arterioscler Thromb Vasc Biol 23 (2003) 1724-1731
5. Kawakami A., and Yoshida M. Remnant lipoproteins and atherogenesis. J Atheroscler Thromb 12 2 (2005) 73-76
6. Milano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I. J Biol Chem 258 (1983) 2508-2513
7. Milano apoprotein with plasma lipid and lipoprotein patterns. Atherosclerosis 58 (1985) 159-174
8. Sirtori C.R., Calabresi L., Franceschini G., et al. Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation 103 (2001) 1949-1954
9. Franceschini G., Calabresi L., Tosi C., et al. Apolipoprotein AIMilano. Disulfide-linked dimers increase high density lipoprotein stability and hinder particle interconversion in carrier plasma. J Biol Chem 265 (1990) 12224-12231
10. Franceschini G., Calabresi L., Chiesa G., et al. Increased cholesterol efflux potential of sera from ApoA-IMilano carriers and transgenic mice. Arterioscler Thromb Vasc Biol 19 (1999) 1257-1262
11. Chiesa G., Monteggia E., Marchesi M., et al. Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res 90 (2002) 974-980
12. Kaul S., Rukshin V., Santos R., et al. Intramural delivery of recombinant apolipoprotein A-IMilano/phospholipid complex (ETC-216) inhibits in-stent stenosis in porcine coronary arteries. Circulation 107 (2003) 2551-2554
13. Bielicki J.K., and Oda M.N. Apolipoprotein A-I(Milano) and apolipoprotein A-I(Paris) exhibit an antioxidant activity distinct from that of wild-type apolipoprotein A-I. Biochemistry 41 (2002) 2089-2096
14. Nissen S.E., Tsunoda T., Tuzcu E.M., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003) 2292-2300
15. Zweier J.L., Flaherty J.T., and Weisfeldt M.L. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84 (1987) 1404-1407
16. Bolli R. Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol 292 (2007) H19-H27
17. Bisgaier C.L., Sachdev O.P., Lee E.S., et al. Effect of lecithin:cholesterol acyltransferase on distribution of apolipoprotein A-IV among lipoproteins of human plasma. J Lipid Res 28 (1987) 693-703
18. Lucchesi B.R. Free radicals and tissue injury. Dialog Cardiovasc Med 1 (1998) 3-22
19. Ambrosio G., Flaherty J.T., Duilio C., et al. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 87 (1991) 2056-2066
20. Navab M., Hama S.Y., Anantharamaiah G.M., et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res 41 (2000) 1495-1508
21. Navab M., Hama S.Y., Cooke C.J., et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res 41 (2000) 1481-1494
22. Calara F., Dimayuga P., Niemann A., et al. An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler Thromb Vasc Biol 18 (1998) 884-893
23. Sivonova M., Tatarkova Z., Durackova Z., et al. Relationship between antioxidant potential and oxidative damage to lipids, proteins and DNA in aged rats. Physiol Res (2006)
24. Calabresi L., Rossoni G., Gomaraschi M., et al. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ Res 92 (2003) 330-337
25. Marchesi M., Booth E.A., Davis T., et al. Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury. J Pharmacol Exp Ther 311 (2004) 1023-1031
26. Ameli S., Hultgardh-Nilsson A., Cercek B., et al. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation 90 (1994) 1935-1941
27. Shah P.K., Wang L., Pan T., et al. Comparative anti-atherogenic effects of macrophage specific expression of apolipoprotein A-I Milano versus apolipoprotein A-I wild type in apo E/apo A-I double knockout mice. Circulation (Supplement) 112 (2005) 258